Free Trial
NASDAQ:CBLL

CeriBell (CBLL) Stock Price, News & Analysis

CeriBell logo
$11.80 -0.53 (-4.30%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$11.79 -0.01 (-0.08%)
As of 09/5/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CeriBell Stock (NASDAQ:CBLL)

Key Stats

Today's Range
$11.73
$12.60
50-Day Range
$11.42
$18.93
52-Week Range
$10.01
$32.75
Volume
273,127 shs
Average Volume
304,335 shs
Market Capitalization
$432.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.14
Consensus Rating
Buy

Company Overview

CeriBell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

CBLL MarketRank™: 

CeriBell scored higher than 54% of companies evaluated by MarketBeat, and ranked 593rd out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CeriBell has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    CeriBell has a consensus price target of $32.14, representing about 172.4% upside from its current price of $11.80.

  • Amount of Analyst Coverage

    CeriBell has only been the subject of 1 research reports in the past 90 days.

  • Read more about CeriBell's stock forecast and price target.
  • Earnings Growth

    Earnings for CeriBell are expected to grow in the coming year, from ($2.46) to ($1.18) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CeriBell is -3.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CeriBell is -3.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CeriBell has a P/B Ratio of 2.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CeriBell's valuation and earnings.
  • Short Interest

    There is no current short interest data available for CBLL.
  • Dividend Yield

    CeriBell does not currently pay a dividend.

  • Dividend Growth

    CeriBell does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CBLL.
  • News Sentiment

    CeriBell has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for CeriBell this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    1 people have added CeriBell to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CeriBell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,126,402.00 in company stock.

  • Percentage Held by Insiders

    20.10% of the stock of CeriBell is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CeriBell's insider trading history.
Receive CBLL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CeriBell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBLL Stock News Headlines

CeriBell (NASDAQ:CBLL) VP David Foehr Sells 866 Shares
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly income to cover housing, healthcare, food, and fun... With a fraction of what you probably think you need.tc pixel
Head to Head Analysis: CeriBell (CBLL) & The Competition
CeriBell (CBLL) vs. Its Competitors Head to Head Review
CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript
See More Headlines

CBLL Stock Analysis - Frequently Asked Questions

CeriBell's stock was trading at $25.88 at the start of the year. Since then, CBLL shares have decreased by 54.4% and is now trading at $11.80.

CeriBell, Inc. (NASDAQ:CBLL) posted its earnings results on Tuesday, August, 5th. The company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.02. The business had revenue of $21.20 million for the quarter, compared to analyst estimates of $20.52 million. CeriBell had a negative trailing twelve-month return on equity of 48.42% and a negative net margin of 63.83%.
Read the conference call transcript
.

CeriBell (CBLL) raised $180 million in an IPO on Friday, October 11th 2024. The company issued 10,606,060 shares at a price of $17.00 per share.

Top institutional investors of CeriBell include Yu Fan (3.69%), Novo Holdings A S (2.45%), TimesSquare Capital Management LLC (2.21%) and Franklin Resources Inc. (1.38%). Insiders that own company stock include Xingjuan Chao, David Foehr and Rebecca B Robertson.
View institutional ownership trends
.

Shares of CBLL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2025
Today
9/06/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CBLL
Previous Symbol
NASDAQ:CBLL
CIK
1861107
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$36.00
Low Price Target
$30.00
Potential Upside/Downside
+172.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.46 million
Net Margins
-63.83%
Pretax Margin
-63.83%
Return on Equity
-48.42%
Return on Assets
-28.50%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
13.31
Quick Ratio
12.91

Sales & Book Value

Annual Sales
$77.42 million
Price / Sales
5.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.34 per share
Price / Book
2.21

Miscellaneous

Outstanding Shares
36,664,000
Free Float
29,295,000
Market Cap
$432.64 million
Optionable
N/A
Beta
N/A

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:CBLL) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners